{"altmetric_id":1288938,"counts":{"readers":{"mendeley":23,"citeulike":0,"connotea":0},"blogs":{"unique_users_count":1,"unique_users":[56597],"posts_count":1},"total":{"posts_count":2},"twitter":{"unique_users_count":1,"unique_users":["VEGFRSSfeeds"],"posts_count":1}},"selected_quotes":["Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated w... PM"],"citation":{"abstract":"There are no validated markers that predict response in metastatic renal cell cancer (RCC) patients treated with sunitinib. We aim to study the impact of single-nucleotide polymorphisms (SNPs) that have recently been proposed as predictors of outcome to anti-VEGF-targeted therapy in metastatic RCC in an independent cohort of patients.","abstract_source":"pubmed","altmetric_jid":"4f6fa4e93cf058f61000243d","authors":["B Beuselinck","A Karadimou","D Lambrechts","B Claes","P Wolter","G Couchy","J Berkers","R Paridaens","P Sch\u00f6ffski","A M\u00e9jean","V Verkarre","E Lerut","A de la Taille","J-M Tourani","P Bigot","C Linassier","S N\u00e9grier","J Berger","J-J Patard","J Zucman-Rossi","S Oudard"],"doi":"10.1038\/bjc.2012.548","endpage":"900","first_seen_on":"2013-03-08T10:49:17+00:00","issns":["1532-1827","0007-0920"],"issue":"4","journal":"British Journal of Cancer","last_mentioned_on":1481707680,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23462807?dopt=Abstract","http:\/\/www.nature.com\/bjc\/journal\/v108\/n4\/full\/bjc2012548a.html"],"pmcid":"PMC3590652","pmid":"23462807","pubdate":"2013-03-05T00:00:00+00:00","publisher":"Nature Publishing Group","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"887","subjects":["neoplasms"],"title":"Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib.","type":"article","volume":"108","mendeley_url":"http:\/\/www.mendeley.com\/research\/singlenucleotide-polymorphisms-associated-outcome-metastatic-renal-cell-carcinoma-treated-sunitinib"},"altmetric_score":{"score":7.25,"score_history":{"1y":5,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":7.25},"context_for_score":{"all":{"total_number_of_other_articles":7885400,"mean":6.6781117138083,"rank":1072363,"this_scored_higher_than_pct":86,"this_scored_higher_than":6805878,"rank_type":"exact","sample_size":7885400,"percentile":86},"similar_age_3m":{"total_number_of_other_articles":116416,"mean":6.5045949748745,"rank":17069,"this_scored_higher_than_pct":85,"this_scored_higher_than":99221,"rank_type":"exact","sample_size":116416,"percentile":85},"this_journal":{"total_number_of_other_articles":4076,"mean":8.9144520245399,"rank":1122,"this_scored_higher_than_pct":72,"this_scored_higher_than":2940,"rank_type":"exact","sample_size":4076,"percentile":72},"similar_age_this_journal_3m":{"total_number_of_other_articles":92,"mean":7.6515604395604,"rank":22,"this_scored_higher_than_pct":76,"this_scored_higher_than":70,"rank_type":"exact","sample_size":92,"percentile":76}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Unspecified":1,"Professor > Associate Professor":2,"Researcher":4,"Student  > Ph. D. Student":7,"Other":4,"Student  > Master":1,"Student  > Bachelor":1,"Professor":3},"by_discipline":{"Medicine and Dentistry":10,"Psychology":1,"Agricultural and Biological Sciences":7,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":4}}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/VEGFRSSfeeds\/statuses\/309978986769956864","license":"public","citation_ids":[1288938],"posted_on":"2013-03-08T10:48:44+00:00","author":{"name":"VEGF RSS Feeds","image":"https:\/\/pbs.twimg.com\/profile_images\/516588600\/VEGF_normal.jpg","id_on_source":"VEGFRSSfeeds","tweeter_id":"88511740","geo":{"lt":null,"ln":null},"followers":363},"tweet_id":"309978986769956864"}],"blogs":[{"title":"Editorial: SNP of the VEGFR \u2013 a promising biomarker in mRCC","url":"http:\/\/www.bjuinternational.com\/article-of-the-week\/editorial-single-nucleotide-polymorphisms-vascular-endothelial-growth-factor-receptor-promising-biomarker-metastatic-renal-cell-carcinoma\/","license":"public","citation_ids":[1644899,14746333,481674,747532,14746344,1288938,9752282,9752282],"posted_on":"2016-12-14T09:28:00+00:00","summary":"Despite earlier detection of localised renal tumours, the resultant tumour down-staging, and an ever-increasing armamentarium of systemic therapies available for metastatic RCC (mRCC), population-level RCC mortality data has failed to show significant imp","author":{"name":"BJUI","url":"http:\/\/www.bjuinternational.com\/","description":"BJU International"}}]}}